Improved proteomic discovery by sample pre-fractionation using dual-column ion-exchange high performance liquid...

Area of Science:

• Biochemistry
• Proteomics
• Analytical Chemistry

Background:

• Clinically relevant biomarkers are essential for disease diagnosis, risk stratification, prognosis, and treatment.
• Identifying protein biomarkers, especially for early-stage diseases, is critical for effective medical interventions.
• The heterogeneity and wide abundance range of proteins in biological samples pose significant challenges to proteomic discovery, even with advanced mass spectrometry.

Purpose of the Study:

• To develop a robust, rapid, and reproducible method for enhancing proteomic detection coverage in complex biological specimens.
• To improve the identification of a broader range of proteins from tissue and cell lysates.
• To facilitate more effective biomarker discovery through advanced proteomic profiling.

Main Methods:

• Development of a high-performance ion-exchange liquid chromatography (HPLC) pre-fractionation technique.
• Application of this method to simplify complex biological specimens prior to proteomic analysis.
• Utilizing basic tandem mass spectrometry for screening of fractionated samples, termed 'fractionomics'.

Main Results:

• The 'fractionomics' approach significantly increases the number of proteins confidently identified in complex samples.
• This method improves proteomic detection coverage compared to direct analysis of unfractionated samples.
• The technique demonstrates robustness, rapidity, and reproducibility for proteomic profiling.

Conclusions:

• The developed HPLC pre-fractionation method, 'fractionomics,' offers a powerful tool for overcoming proteomic challenges in complex biological samples.
• This approach enhances the discovery of clinically relevant protein biomarkers for improved diagnostics and therapeutics.
• Fractionomics provides a more comprehensive proteomic analysis, advancing biomedical research and applications.